Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Graff

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Psychiatry|March 21, 2012
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's diseaseJ-C Lambert, B Grenier-Boley, D Harold, et al.
Nature Genetics|October 29, 2013
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseJ C Lambert, C A Ibrahim-Verbaas, D Harold, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Psychiatry|March 21, 2012
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's diseaseJ-C Lambert, B Grenier-Boley, D Harold, et al.
Nature Genetics|October 29, 2013
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseJ C Lambert, C A Ibrahim-Verbaas, D Harold, et al.
Pageof 13